INCOME TAXES

12 Months Ended

Mar. 28, 2020

Domestic and foreign income before provision for income tax is as follows:



(In thousands)	2020		2019		2018
Domestic	$	5,344	$	26,665	$	3,534
Foreign	81,808		46,968		56,098
Total	$	87,152	$	73,633	$	59,632

The income tax provision from continuing operations contains the following components:



(In thousands)	2020			2019			2018
Current
Federal	$	3,834		$	(4,165	)	$	9,927
State	1,054			844			1,024
Foreign	12,467			8,584			8,937
Total current	$	17,355		$	5,263		$	19,888
Deferred
Federal	(8,257		)	12,220			(5,350		)
State	280			463			344
Foreign	1,248			668			(822		)
Total deferred	$	(6,729	)	$	13,351		$	(5,828	)
Total	$	10,626		$	18,614		$	14,060

The Company conducts business globally and reports its results of operations in a number of foreign jurisdictions in addition to the United States. The Company's reported tax rate is impacted by the jurisdictional mix of earnings in any given period as the foreign jurisdictions in which it operates have tax rates that differ from the U.S. statutory tax rate.

Beginning in fiscal 2019, the Company incorporated certain provisions of the Tax Cuts and Jobs Act (the "Act") in the calculation of the tax provision and effective tax rate, including the provisions related to global intangible low taxed income (“GILTI”), foreign derived intangible income (“FDII”), base erosion anti abuse Tax (“BEAT”), as well as other provisions which limit tax deductibility of expenses. For fiscal 2020, the GILTI provisions have the most significant impact to the Company. Under the new law, U.S. taxes are imposed on foreign income in excess of a deemed return on tangible assets of its foreign subsidiaries. The ability to benefit from a deduction and foreign tax credits against a portion of the GILTI income may be limited under the GILTI rules as a result of the utilization of net operating losses, foreign sourced income, and other potential limitations within the foreign tax credit calculation.

Interpretive guidance on the accounting for GILTI states that an entity can make an accounting policy election to either recognize deferred taxes for temporary basis differences expected to reverse as GILTI in future years or provide for the tax expense related to GILTI in the year the tax is incurred as a period expense only. The Company has made the accounting policy election to recognize GILTI as a period expense.

The Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was enacted in the United States on March 27, 2020. The CARES Act is an emergency economic stimulus package that includes spending and tax breaks to strengthen the United States economy and fund a nationwide effort to curtail the effect of COVID-19. While the CARES Act provides extensive tax changes in response to the COVID-19 pandemic, the provisions are not expected to have a significant impact on the Company’s financial results.

The Company's subsidiary in Puerto Rico has been granted a fifteen-year tax grant that expires in calendar 2027. Its qualification for the tax grant is dependent on the continuation of its manufacturing activities in Puerto Rico. The Company benefits from a reduced tax rate on its earnings in Puerto Rico under the tax grant.

The Company's subsidiary in Malaysia has been granted a full income tax exemption to manufacture whole blood and apheresis devices that could be in effect for up to ten years, provided certain conditions are satisfied. The income tax exemption was in effect beginning June 1, 2016.

Tax affected, significant temporary differences comprising the net deferred tax liability are as follows:



(In thousands)	March 28, 2020			March 30, 2019
Deferred tax assets:
Depreciation	$	1,922		$	2,277
Amortization of intangibles	1,156			1,091
Inventory	2,904			3,541
Accruals, reserves and other deferred tax assets	17,345			15,802
Net operating loss carry-forward	4,953			4,931
Stock based compensation	3,634			3,728
Operating lease liabilities	14,115			—
Tax credit carry-forward, net	5,159			4,176
Capitalized research expenses	3,820			—
Gross deferred tax assets	55,008			35,546
Less valuation allowance	(14,587		)	(11,322		)
Total deferred tax assets (after valuation allowance)	40,421			24,224
Deferred tax liabilities:
Depreciation	(15,840		)	(23,102		)
Amortization of goodwill and intangibles	(15,450		)	(13,959		)
Unremitted earnings	(654		)	(801		)
Operating lease assets	(12,743		)	—
Other deferred tax liabilities	(2,366		)	(1,909		)
Total deferred tax liabilities	(47,053		)	(39,771		)
Net deferred tax liabilities	$	(6,632	)	$	(15,547	)

The valuation allowance increased by $3.3 million during fiscal 2020, primarily as a result of net operating losses and tax credits generated in jurisdictions in which the Company has concluded that its deferred tax assets are not more-likely-than-not realizable. The Company has assessed, on a jurisdictional basis, the available means of recovering deferred tax assets, including the ability to carry-back net operating losses, the existence of reversing temporary differences, the availability of tax planning strategies and available sources of future taxable income. It has also considered the ability to implement certain strategies that would, if necessary, be implemented to accelerate taxable income and use expiring deferred tax assets. The Company has concluded future taxable income can be considered a source of income to realize a benefit for deferred tax assets in certain jurisdictions. In addition, the Company has concluded that it cannot rely on future taxable income in certain risk bearing principal jurisdictions due uncertainty surrounding future taxable income (including as a result of the effects of Covid-19). The Company believes it is able to support the deferred tax assets recognized as of the end of the year based on all of the available evidence. The worldwide net deferred tax liability as of March 28, 2020 includes deferred tax liabilities related to amortizable tax basis in goodwill, which are indefinite lived and can only be used as a source of income to benefit other indefinite lived assets.

As of March 28, 2020, the Company maintains a valuation allowance against certain U.S. deferred tax assets that are not more-likely-than-not realizable and maintains a full valuation allowance against the net deferred tax assets of certain foreign subsidiaries.

As of March 28, 2020, the Company has no U.S. federal net operating loss carryforwards. The Company has U.S. state net operating losses of $35.6 million of which $30.3 million will begin to expire in fiscal 2021 and $5.3 million can be carried

forward indefinitely. The Company has federal and state tax research credits of $1.3 million and $4.9 million, respectively, which will begin to expire in fiscal 2039 and fiscal 2025, respectively.

The Company's net operating loss and tax credit carry-forwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a three-year period in excess of 50 percent as defined under Section 382 and 383 of the U.S. Internal Revenue Code of 1986, respectively, as well as similar state provisions. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. The Company conducted a Section 382 study covering the period April 2, 2011 through December 31, 2017. The study concluded that there were no limitations on the Company’s net operating losses and tax credit carryforwards as of December 31, 2017. The Company does not believe it has had an ownership change through March 28, 2020. Subsequent ownership changes may further affect the limitation in future years.

As of March 28, 2020, the Company has foreign net operating losses of approximately $14.6 million that are available to reduce future income of which $5.5 million will begin to expire in fiscal 2034 and $9.1 million can be carried forward indefinitely.

As of March 28, 2020, substantially all of the unremitted earnings of the Company have been taxed in the U.S. The Company has provided $0.4 million of net foreign withholding taxes on approximately $178.3 million of unremitted earnings that are not indefinitely reinvested. The Company has not provided U.S. deferred income taxes or foreign withholding taxes on unremitted earnings of foreign subsidiaries of approximately $242.0 million as such amounts are considered to be indefinitely reinvested in the business. The accumulated earnings in the foreign subsidiaries are primarily utilized to fund working capital requirements as its subsidiaries continue to expand their operations, to service existing debt obligations and to fund future foreign acquisitions. The Company does not believe it is practicable to estimate the amount of income taxes payable on the earnings that are indefinitely reinvested in foreign operations, however a significant portion of the unremitted earnings could be remitted without a future tax cost.

The income tax provision from continuing operations differs from tax provision computed at the U.S. federal statutory income tax rate due to the following:



(In thousands)	2020					2019					2018
Tax at federal statutory rate	$	18,302		21.0	%	$	15,463		21.0	%	$	18,807		31.5	%
Difference between U.S. and foreign tax	(6,688		)	(7.7	)%	(1,423		)	(1.9	)%	(9,264		)	(15.5	)%
State income taxes net of federal benefit	(342		)	(0.4	)%	902			1.2	%	29			—	%
Change in uncertain tax positions	785			0.9	%	267			0.4	%	1,095			1.8	%
Global intangible low taxed income	5,431			6.2	%	5,954			8.1	%	—			—	%
Unremitted earnings	40			—	%	527			0.7	%	(791		)	(1.3	)%
Deferred statutory rate changes	1,091			1.3	%	1,183			1.6	%	(3,193		)	(5.4	)%
Non-deductible executive compensation	2,423			2.8	%	1,588			2.2	%	221			0.4	%
Non-deductible other	1,050			1.2	%	462			0.6	%	22			—	%
Stock compensation benefits	(12,133		)	(13.9	)%	(5,382		)	(7.3	)%	(2,544		)	(4.3	)%
Research credits	(2,085		)	(2.4	)%	(768		)	(1.0	)%	(763		)	(1.3	)%
One-time transition tax from tax reform	—			—	%	26			—	%	25,798			43.3	%
Valuation allowance	2,939			3.4	%	(184		)	(0.3	)%	(15,541		)	(25.9	)%
Other, net	(187		)	(0.2	)%	(1		)	—	%	184			0.3	%
Income tax provision (benefit)	$	10,626		12.2	%	$	18,614		25.3	%	$	14,060		23.6	%

The Company recorded an income tax provision of $10.6 million, representing an effective tax rate of 12.2%. The effective tax rate is lower than the U.S. statutory rate of 21.0% primarily as a result of the impact of tax benefits of stock compensation windfall deductions; research credits generated and jurisdictional mix of earnings, partially offset by the impact of GILTI, non-deductible executive compensation, tax reserves and changes in valuation allowance. The Company has recorded an immaterial tax expense related to unremitted foreign earnings that are not considered permanently reinvested.

Unrecognized Tax Benefits

Unrecognized tax benefits represent uncertain tax positions for which reserves have been established. As of March 28, 2020, the Company had $4.6 million of unrecognized tax benefits, of which $4.0 million would impact the effective tax rate, if recognized. As of March 30, 2019, the Company had $4.7 million of unrecognized tax benefits, of which $3.9 million would impact the effective tax rate, if recognized. At March 31, 2018, the Company had $4.5 million of unrecognized tax benefits, of which $3.8 million would impact the effective tax rate, if recognized.

During the fiscal year ended March 28, 2020, the Company's unrecognized tax benefits were decreased by an immaterial amount, primarily relating to uncertain tax positions established against foreign tax provisions and various federal and state tax credits offset by the settlement of prior exposures.

The following table summarizes the activity related to its gross unrecognized tax benefits for the fiscal years ended March 28, 2020, March 30, 2019 and March 31, 2018:



(In thousands)	March 28, 2020			March 30, 2019			March 31, 2018
Beginning Balance	$	4,657		$	4,450		$	3,370
Additions for tax positions of current year	180			282			289
Additions for tax positions of prior years	880			—			1,203
Reductions of tax positions	(539		)	(52		)	(252		)
Settlements of tax positions	(558		)	—			—
Closure of statute of limitations	—			(23		)	(160		)
Ending Balance	$	4,620		$	4,657		$	4,450

As of March 28, 2020, the Company anticipates that the liability for unrecognized tax benefits for uncertain tax positions could change by up to $1.4 million in the next twelve months, as a result of closure of various statutes of limitations and potential settlements with tax authorities.

The Company's historical practice has been and continues to be to recognize interest and penalties related to federal, state and foreign income tax matters in income tax expense. Approximately $0.4 million, $0.2 million, and $0.2 million of gross interest and penalties were accrued at March 28, 2020, March 30, 2019, and March 31, 2018, respectively, and are not included in the amounts above. Additionally, $0.3 million of accrued interest and penalties was included in income tax expense for the year ended March 28, 2020. Such amounts were immaterial during the fiscal years ended March 30, 2019 and March 31, 2018.

The Company conducts business globally and, as a result, files federal, state and foreign income tax returns in multiple jurisdictions. In the normal course of business, it is subject to examination by taxing authorities throughout the world. With a few exceptions, the Company is no longer subject to U.S. federal, state, or local income tax examinations for years before fiscal 2016 and foreign income tax examinations for years before fiscal 2015. To the extent that the Company has tax attribute carry-forwards, the tax years in which the attribute was generated may still be adjusted upon examination by the Internal Revenue Service, state, or foreign tax authorities to the extent utilized in a future period.